Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL78796 | 0.95 | CYP3A4 (0.30) | CYP3A4 | |
| SCHEMBL22535914 | 0.94 | CYP3A4 (0.32) | CYP3A4TSHRCASP1 | |
| SCHEMBL20144 | 0.92 | CYP3A4 (0.31) | CYP3A4 | |
| Ammonia Solution, Strong SCHEMBL28288673 | 0.89 | CYP3A4 (0.30) | CYP3A4 | |
| Cyclohexane SCHEMBL28101384 | 0.85 | — | — | |
| SCHEMBL27739772 | 0.85 | — | — | |
| SCHEMBL28309334 | 0.85 | — | — | |
| Carbimide SCHEMBL28988925 | 0.85 | — | — | |
| SCHEMBL29619540 | 0.85 | — | — | |
| SCHEMBL8387338 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 420 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114144447-B | Poly (arylene ether) composition | 高新特殊工程塑料全球技术有限公司 | 2023-08-22 | — | — | CN | claimed |
| CN-116533420-A | Preparation method of near infrared barrier polyurethane lens | 浙江伟星光学股份有限公司 | 2023-08-04 | — | — | CN | claimed |
| CN-115612096-A | Polyoxazolidinone prepolymer and preparation method and application thereof | 广州市嵩达新材料科技有限公司 | 2023-01-17 | — | — | CN | claimed |
| CN-115490828-A | Modified polyoxazolidone prepolymer and high-temperature-resistant photocuring adhesive based on same | 广州市嵩达新材料科技有限公司 | 2022-12-20 | — | — | CN | claimed |
| US-20160251472-A1 | POLYFUNCTIONAL URETHANE (METH)ACRYLATES COMPRISING LOW-MONOMER-CONTENT DIISOCYANATE MONOADDUCTS | EVONIK DEGUSSA GMBH (DE) | 2016-09-01 | — | — | US | claimed |
| US-8841479-B2 | Low monomer 1 : 1 monoadducts of reactive olefinic compounds and diisocyanates using insertable inhibitors | EVONIK DEGUSSA GMBH (DE) | 2014-09-23 | — | — | US | claimed |
| CN-102292371-B | Low monomer 1 : 1 monoadducts of reactive olefinic compounds and diisocyanates using insertable inhibitors | EVONIK DEGUSSA GMBH | 2014-09-17 | — | — | CN | claimed |
| EP-2367864-B1 | LOW MONOMER 1 : 1 MONOADDUCTS OF REACTIVE OLEFINIC COMPOUNDS AND DIISOCYANATES USING INSERTABLE INHIBITORS | EVONIK DEGUSSA GMBH (DE) | 2012-10-03 | — | — | EP | claimed |
| US-20110251424-A1 | LOW MONOMER 1 : 1 MONOADDUCTS OF REACTIVE OLEFINIC COMPOUNDS AND DIISOCYANATES USING INSERTABLE INHIBITORS | EVONIK DEGUSSA GMBH (DE) | 2011-10-13 | — | — | US | claimed |
| EP-1136495-B1 | 1:1 monoadducts of aminoalkylalkoxysilanes and diisocyanates, their preparation and use | DEGUSSA (DE) | 2006-06-28 | — | — | EP | claimed |
| US-20260137080-A1 | EARLY APPLICATIONS OF ENCAPSULATED ACETAMIDES FOR REDUCED INJURY IN CROPS | MONSANTO TECH LLC (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4731688-A1 | METHOD FOR THE PRODUCTION OF A HYDROXYL-GROUP TERMINATED OXAZOLIDINONE COMPOSITION | Covestro Deutschland AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-12606715-B2 | Aqueous ink composition for writing instruments | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2026-04-21 | — | — | US | disclosed |
| US-12577418-B2 | Ink composition for water-based ballpoint pens | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2026-03-17 | — | — | US | disclosed |
| US-20260071091-A1 | SELF-HEALING TRANSPARENT COATING COMPOSITION USING SUNLIGHT AND APPLICATION THEREOF | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2026-03-12 | — | — | US | disclosed |
| EP-0390218-A2 | Anti-reflection optical element | HOYA CORPORATION (JP) | 1990-10-03 | — | — | EP | disclosed |
| EP-0017998-B2 | Process for continuous preparation of (cyclo)-aliphatic polyisocyanates containing isocyanurate groups | HÜLS AKTIENGESELLSCHAFT (DE) | 1988-10-26 | — | — | EP | disclosed |
| US-4454317-A | USING VERY LOW CONCENTRATIONS OF A QUATERNARY N-/HYDROXYALKYL/AMMONIUM SALT OF AN ORGANIC ACID | CHEMISCHE WERKE HULS AKTIENGESELLSCHAFT (DE) | 1984-06-12 | — | — | US | disclosed |
| EP-0017998-A1 | Process for continuous preparation of (cyclo)-aliphatic polyisocyanates containing isocyanurate groups | HÜLS AKTIENGESELLSCHAFT (DE) | 1980-10-29 | — | — | EP | disclosed |
| US-4049632-A | Chain extending polyurethanes with a large excess of water | ARMSTRONG CORK COMPANY (US) | 1977-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577418-B2 | Ink composition for water-based ballpoint pens | UTP18, U2AF1, WDR12 | CYP3A4 4356/4885TSHR 4530/4885CASP1 1390/4885 |
| US-20260071091-A1 | SELF-HEALING TRANSPARENT COATING COMPOSITION USING SUNLIGHT AND APPLICATION THEREOF | PCNA, CUTA, COL1A1 | CYP3A4 1830/4885TSHR 4154/4885CASP1 988/4885 |
| US-20260137080-A1 | EARLY APPLICATIONS OF ENCAPSULATED ACETAMIDES FOR REDUCED INJURY IN CROPS | SRM, PFAS, ACMSD | CYP3A4 4086/4885TSHR 1596/4885CASP1 892/4885 |
| US-12606715-B2 | Aqueous ink composition for writing instruments | UTP18, PUF60, EXOSC10 | CYP3A4 4503/4885TSHR 4430/4885CASP1 3919/4885 |
| US-20110251424-A1 | LOW MONOMER 1 : 1 MONOADDUCTS OF REACTIVE OLEFINIC COMPOUNDS AND DIISOCYANATES USING INSERTABLE INHIBITORS | CYP1B1, HCFC1, DIMT1 | CYP3A4 226/4885TSHR 4848/4885CASP1 824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.